AstraZeneca Cuts Sales Reps By Reducing PDI Contract; Will Others Follow?
Executive Summary
AstraZeneca's decision to reduce the number of contract sales reps may be an early indicator of an industry trend in 2005
You may also be interested in...
Novartis To Maintain Sales Force In Face Of Potential Competitor Cutbacks
Novartis' decision to maintain its current sales force level could reflect the company's confidence in the continued growth of its pharmaceutical business
Novartis To Maintain Sales Force In Face Of Potential Competitor Cutbacks
Novartis' decision to maintain its current sales force level could reflect the company's confidence in the continued growth of its pharmaceutical business
Sales Force Downsizing By Big Pharma Means Small/Mid-Tier Boom, CSOs Say
Sales force restructuring among large pharmaceutical companies is helping to drive contract sales agreements with small and mid-tier companies, contract sales organizations say